Core Scientific, Inc./tx

For the period ended Mar 31, 2026. Filed May 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

CORZ$13.13+3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

(in thousands)

For the Three Months Ended March 31, 2026

Common Stock · AdditionalPaid-In Capital · AccumulatedDeficit · TotalStockholders’Deficit
Shares · Amount
Balance at January 1, 2026	314,231	3	3,183,960	(4,146,703)	(962,740)
Net loss	—	—	—	(347,188)	(347,188)
Stock-based compensation	—	—	18,387	—	18,387
Restricted stock awards issued	3,690	—	655	—	655
Restricted stock awards withheld for tax withholding obligations	(1,359)	—	(21,651)	—	(21,651)
Exercise of warrants	387	—	6,851	—	6,851
Balance at March 31, 2026	316,949	$3	$3,188,202	$(4,493,891)	$(1,305,686)

For the Three Months Ended March 31, 2025

Common Stock · AdditionalPaid-In Capital · AccumulatedDeficit · TotalStockholders’Deficit
Shares · Amount
Balance at January 1, 2025	292,606	3	2,915,035	(3,858,087)	(943,049)
Net income	—	—	—	576,251	576,251
Stock-based compensation	—	—	16,405	—	16,405
Restricted stock awards issued	2,981	—	(50)	—	(50)
Exercise of warrants	3,500	$—	41,625	—	41,625
Balance at March 31, 2025	299,087	$3	$2,973,015	$(3,281,836)	$(308,818)

1 Proceeds from digital assets received as noncash revenue consideration liquidated upon management's discretion.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.